In Russia, failures began with the import of glucose monitoring systems, necessary for people suffering from diabetes. Natalya Mokrysheva, director of the National Medical Research Center (NMRC) of Endocrinology, told “Kommersant” about this.
Continuous glucose monitoring (CMG) systems check the condition of diabetics every few minutes. Medtronic products consist of a sensor sensor that measures glucose levels, which is replaced every few days.
After the United States included components for such systems in the list of dual-purpose products, medical products of the Irish-American company Medtronic became unavailable in Russia.
Information about the lack of sensors of this company was confirmed to journalists by the health committee of St. Petersburg and Moscow suppliers. Medtronic itself told “Kommersant” that their employees are “working to ensure stable supplies” of production to Russia.
So far, there is a product from the American company Abbott on the Russian market, but it is not intended for children under the age of four suffering from diabetes.
In August, according to Kommersant, Roszdravnadzor registered the country’s first Chinese glucose monitoring system. However, according to Natalya Mokrysheva, director of the National Medical Center of Endocrinology, it does not meet the “requirements for patients”.